Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | NT5E | P21589 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.61 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.61 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14929125 | 1.00 | CYP2C19 (0.62) | CYP2C19LMNANT5EHIF1AADORA2A | |
| SCHEMBL14931005 | 1.00 | CYP2C19 (0.62) | CYP2C19LMNANT5EHIF1AADORA2A | |
| SCHEMBL18844803 | 1.00 | CYP2C19 (0.62) | CYP2C19LMNANT5EHIF1AADORA2A | |
| SCHEMBL343478 | 1.00 | CYP2C19 (0.62) | CYP2C19LMNANT5EHIF1AADORA2A | |
| SCHEMBL18512921 | 1.00 | CYP2C19 (0.62) | CYP2C19LMNANT5EHIF1AADORA2A | |
| SCHEMBL25101160 | 0.99 | CYP2C19 (0.61) | CYP2C19LMNANT5EHIF1AADORA2A | |
| Hydrochloric Acid SCHEMBL5972606 | 0.99 | CYP2C19 (0.61) | CYP2C19LMNANT5EHIF1AADORA2A | |
| SCHEMBL29388779 | 0.99 | CYP2C19 (0.61) | CYP2C19LMNANT5EHIF1AADORA2A | |
| Phosphoric Acid SCHEMBL5747244 | 0.96 | CYP2C19 (0.58) | CYP2C19LMNANT5EHIF1AADORA2A | |
| SCHEMBL1065981 | 0.96 | CYP2C19 (0.58) | CYP2C19LMNANT5EHIF1AADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9477 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070938-A | Method for improving anti-tumor response by enhancing cellular immune response | 四川大学 | 2026-05-22 | — | — | CN | claimed |
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| CN-122055140-A | Pharmaceutical composition containing nucleic acid construct and medical application thereof | 上海瑞宏迪医药有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| US-20260069717-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | MODERNATX INC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4705468-A1 | MAMMALIAN POLYCISTRONIC EXPRESSION SYSTEM FOR DIRECT TRANSLATION FROM RNA AND SECRETION OF CARGO | California Institute of Technology (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-12503720-B2 | Multiplexed profiling of RNA and DNA modifications | Alida Biosciences Inc. (US) | 2025-12-23 | — | — | US | claimed |
| EP-4661900-A1 | IMMUNE EFFECTOR CELLS STABLY AND TRANSIENTLY EXPRESSING NUCLEIC ACIDS | BIONTECH CELL & GENE THERAPIES GMBH (DE) | 2025-12-17 | — | — | EP | claimed |
| EP-4658809-A1 | CAPPING ASSAY | Seqirus Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| US-20030119764-A1 | Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2003-06-26 | — | — | US | claimed |
| US-20030007961-A1 | Orthomolecular vitamin E derivatives | WILBURN MICHAEL D (US) | 2003-01-09 | — | — | US | claimed |
| EP-0948256-A1 | INDUCTION OF VIRAL MUTATION BY INCORPORATION OF MISCODING RIBONUCLEOSIDE ANALOGS INTO VIRAL RNA | THE UNIVERSITY OF WASHINGTON (US) | 1999-10-13 | — | — | EP | claimed |
| WO-1998018324-A1 | INDUCTION OF VIRAL MUTATION BY INCORPORATION OF MISCODING RIBONUCLEOSIDE ANALOGS INTO VIRAL RNA | THE UNIVERSITY OF WASHINGTON (US) | 1998-05-07 | — | — | WO | claimed |
| EP-0795029-A1 | CHEMICAL LABELLING OF OBJECTS | Pabio (NO) | 1997-09-17 | — | — | EP | claimed |
| EP-0770144-A1 | NUCLEIC ACID AMPLIFICATION METHOD USING A MODIFIED NUCLEOSIDE, AND DETECTION OF THE AMPLIFICATION PRODUCT USING ANTIBODIES | PARTEUROP DEVELOPPEMENT (FR) | 1997-05-02 | — | — | EP | claimed |
| WO-1996017954-A1 | CHEMICAL LABELLING OF OBJECTS | PABIO (DK) | 1996-06-13 | — | — | WO | claimed |
| WO-1996003526-A1 | NUCLEIC ACID AMPLIFICATION METHOD USING A MODIFIED NUCLEOSIDE, AND DETECTION OF THE AMPLIFICATION PRODUCT USING ANTIBODIES | PARTEUROP DEVELOPPEMENT (FR) | 1996-02-08 | — | — | WO | claimed |
| US-5075225-A | PROCESS FOR THE ENZYMATIC SYNTHESIS OF NUCLEOSIDES | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 1991-12-24 | — | — | US | claimed |
| EP-0391592-A1 | Process for the enzymatic synthesis of nucleosides | THE TEXAS A & M UNIVERSITY SYSTEM (US) | 1990-10-10 | — | — | EP | claimed |